387 related articles for article (PubMed ID: 32564303)
1. Diallyl Trisulfide Suppresses Angiotensin II-Induced Vascular Remodeling Via Inhibition of Mitochondrial Fission.
Lu ZY; Qi J; Yang B; Cao HL; Wang RY; Wang X; Chi RF; Guo CL; Yang ZM; Liu HM; Li B
Cardiovasc Drugs Ther; 2020 Oct; 34(5):605-618. PubMed ID: 32564303
[TBL] [Abstract][Full Text] [Related]
2. Targeting HSP90 attenuates angiotensin II-induced adventitial remodelling via suppression of mitochondrial fission.
Huang G; Cong Z; Wang X; Yuan Y; Xu R; Lu Z; Wang X; Qi J
Cardiovasc Res; 2020 Apr; 116(5):1071-1084. PubMed ID: 31346611
[TBL] [Abstract][Full Text] [Related]
3. Mdivi-1, a mitochondrial fission inhibitor, reduces angiotensin-II- induced hypertension by mediating VSMC phenotypic switch.
Deng Y; Li S; Chen Z; Wang W; Geng B; Cai J
Biomed Pharmacother; 2021 Aug; 140():111689. PubMed ID: 34004510
[TBL] [Abstract][Full Text] [Related]
4. Activation of M3AChR (Type 3 Muscarinic Acetylcholine Receptor) and Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) Signaling by Choline Alleviates Vascular Smooth Muscle Cell Phenotypic Switching and Vascular Remodeling.
He X; Deng J; Yu XJ; Yang S; Yang Y; Zang WJ
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2649-2664. PubMed ID: 32938216
[TBL] [Abstract][Full Text] [Related]
5. Targeting mitochondrial fission as a potential therapeutic for abdominal aortic aneurysm.
Cooper HA; Cicalese S; Preston KJ; Kawai T; Okuno K; Choi ET; Kasahara S; Uchida HA; Otaka N; Scalia R; Rizzo V; Eguchi S
Cardiovasc Res; 2021 Feb; 117(3):971-982. PubMed ID: 32384150
[TBL] [Abstract][Full Text] [Related]
6. Diallyl trisulfide attenuates hyperglycemia-induced endothelial apoptosis by inhibition of Drp1-mediated mitochondrial fission.
Hao Y; Liu HM; Wei X; Gong X; Lu ZY; Huang ZH
Acta Diabetol; 2019 Nov; 56(11):1177-1189. PubMed ID: 31115753
[TBL] [Abstract][Full Text] [Related]
7. AKAP1 alleviates VSMC phenotypic modulation and neointima formation by inhibiting Drp1-dependent mitochondrial fission.
Sun J; Shao Y; Pei L; Zhu Q; Yu X; Yao W
Biomed Pharmacother; 2024 Jul; 176():116858. PubMed ID: 38850669
[TBL] [Abstract][Full Text] [Related]
8. RhoGDI stability is regulated by SUMOylation and ubiquitination via the AT1 receptor and participates in Ang II-induced smooth muscle proliferation and vascular remodeling.
Dai F; Qi Y; Guan W; Meng G; Liu Z; Zhang T; Yao W
Atherosclerosis; 2019 Sep; 288():124-136. PubMed ID: 31362179
[TBL] [Abstract][Full Text] [Related]
9. Macrophage (Drp1) Dynamin-Related Protein 1 Accelerates Intimal Thickening After Vascular Injury.
Umezu R; Koga JI; Matoba T; Katsuki S; Wang L; Hasuzawa N; Nomura M; Tsutsui H; Egashira K
Arterioscler Thromb Vasc Biol; 2020 Jul; 40(7):e214-e226. PubMed ID: 32493171
[TBL] [Abstract][Full Text] [Related]
10. HDAC5 inhibition reduces angiotensin II-induced vascular contraction, hypertrophy, and oxidative stress in a mouse model.
Bai L; Kee HJ; Choi SY; Seok YM; Kim GR; Kee SJ; Kook H; Jeong MH
Biomed Pharmacother; 2021 Feb; 134():111162. PubMed ID: 33360932
[TBL] [Abstract][Full Text] [Related]
11. Sauchinone inhibits angiotensin II-induced proliferation and migration of vascular smooth muscle cells.
Wang Y; Li X; Huang X; Ma S; Xing Y; Geng X; He X
Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):220-226. PubMed ID: 31587339
[TBL] [Abstract][Full Text] [Related]
12. Vascular smooth muscle cell-specific miRNA-214 knockout inhibits angiotensin II-induced hypertension through upregulation of Smad7.
Li Y; Li H; Xing W; Li J; Du R; Cao D; Wang Y; Yang X; Zhong G; Zhao Y; Sun W; Liu C; Gao X; Li Y; Liu Z; Jin X; Zhao D; Tan Y; Wang Y; Liu S; Yuan M; Song J; Chang YZ; Gao F; Ling S; Li Y
FASEB J; 2021 Nov; 35(11):e21947. PubMed ID: 34637552
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-(1-7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: Role of the NFкB inflammatory pathway.
Bihl JC; Zhang C; Zhao Y; Xiao X; Ma X; Chen Y; Chen S; Zhao B; Chen Y
Vascul Pharmacol; 2015 Oct; 73():115-123. PubMed ID: 26264508
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 Gene Deletion Attenuates Angiotensin II-Induced Phenotypic Transformation of Vascular Smooth Muscle Cells and Vascular Remodeling.
Ren XS; Tong Y; Ling L; Chen D; Sun HJ; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
Cell Physiol Biochem; 2017; 44(6):2269-2280. PubMed ID: 29262411
[TBL] [Abstract][Full Text] [Related]
15. Yes-associated protein mediates angiotensin II-induced vascular smooth muscle cell phenotypic modulation and hypertensive vascular remodelling.
Lin M; Yuan W; Su Z; Lin C; Huang T; Chen Y; Wang J
Cell Prolif; 2018 Dec; 51(6):e12517. PubMed ID: 30156340
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species derived from NADPH oxidase 1 and mitochondria mediate angiotensin II-induced smooth muscle cell senescence.
Tsai IC; Pan ZC; Cheng HP; Liu CH; Lin BT; Jiang MJ
J Mol Cell Cardiol; 2016 Sep; 98():18-27. PubMed ID: 27381955
[TBL] [Abstract][Full Text] [Related]
17. Regulation of mitochondrial morphology by positive feedback interaction between PKCδ and Drp1 in vascular smooth muscle cell.
Lim S; Lee SY; Seo HH; Ham O; Lee C; Park JH; Lee J; Seung M; Yun I; Han SM; Lee S; Choi E; Hwang KC
J Cell Biochem; 2015 Apr; 116(4):648-60. PubMed ID: 25399916
[TBL] [Abstract][Full Text] [Related]
18. Astaxanthin Attenuates Hypertensive Vascular Remodeling by Protecting Vascular Smooth Muscle Cells from Oxidative Stress-Induced Mitochondrial Dysfunction.
Chen Y; Li S; Guo Y; Yu H; Bao Y; Xin X; Yang H; Ni X; Wu N; Jia D
Oxid Med Cell Longev; 2020; 2020():4629189. PubMed ID: 32351673
[TBL] [Abstract][Full Text] [Related]
19. CD38 deficiency alleviates Ang II-induced vascular remodeling by inhibiting small extracellular vesicle-mediated vascular smooth muscle cell senescence in mice.
Gan L; Liu D; Liu J; Chen E; Chen C; Liu L; Hu H; Guan X; Ma W; Zhang Y; He Y; Liu B; Tang S; Jiang W; Xue J; Xin H
Signal Transduct Target Ther; 2021 Jun; 6(1):223. PubMed ID: 34112762
[TBL] [Abstract][Full Text] [Related]
20. Alamandine attenuates angiotensin II-induced vascular fibrosis via inhibiting p38 MAPK pathway.
Yang C; Wu X; Shen Y; Liu C; Kong X; Li P
Eur J Pharmacol; 2020 Sep; 883():173384. PubMed ID: 32707188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
